International Assets Investment Management LLC Purchases 58,715 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

International Assets Investment Management LLC boosted its position in ARK Genomic Revolution ETF (BATS:ARKG) by 120.1% during the fourth quarter, HoldingsChannel reports. The fund owned 107,617 shares of the company’s stock after buying an additional 58,715 shares during the quarter. International Assets Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $3,280,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wells Fargo & Company MN raised its position in shares of ARK Genomic Revolution ETF by 11.2% in the second quarter. Wells Fargo & Company MN now owns 2,752,614 shares of the company’s stock valued at $93,837,000 after purchasing an additional 277,885 shares during the period. Royal Bank of Canada raised its holdings in ARK Genomic Revolution ETF by 7.5% during the 3rd quarter. Royal Bank of Canada now owns 234,507 shares of the company’s stock valued at $6,533,000 after acquiring an additional 16,433 shares during the period. SG Americas Securities LLC raised its holdings in ARK Genomic Revolution ETF by 835.6% during the 4th quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock valued at $6,990,000 after acquiring an additional 190,287 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of ARK Genomic Revolution ETF by 4.7% in the second quarter. JPMorgan Chase & Co. now owns 193,545 shares of the company’s stock worth $6,598,000 after acquiring an additional 8,712 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of ARK Genomic Revolution ETF by 12.9% in the second quarter. Goldman Sachs Group Inc. now owns 125,037 shares of the company’s stock worth $4,263,000 after acquiring an additional 14,289 shares during the period.

ARK Genomic Revolution ETF Price Performance

Shares of BATS ARKG opened at $23.58 on Thursday. The company has a fifty day moving average of $29.08 and a two-hundred day moving average of $28.49.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.